(Q53942854)

22 May 2018

reason for preferred rank

title

Primary hepatocellular carcinoma—etiology, pathogenesis, and prevention (English)

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

14 September 2023

Primary hepatocellular carcinoma--etiology, pathogenesis, and prevention (English)

1 reference

PubMed ID

6277763

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277763

14 September 2023

1 reference

W. T. London

1

1 reference

PubMed ID

6277763

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277763

14 September 2023

language of work or name

English

0 references

publication date

1 December 1981

1 reference

22 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0046817781803292?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

https://api.elsevier.com/content/article/PII:S0046817781803292?httpAccept=text/plain

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

14 September 2023

1 reference

22 May 2018

volume

12

1 reference

22 May 2018

page(s)

1085-1097

1 reference

22 May 2018

issue

12

1 reference

22 May 2018

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Forecasting the Development of Primary Hepatocellular Carcinoma by the Use of Risk Factors: Studies in West Africa 2 3

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B antigen in the liver cells in cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B virus DNA in primary hepatocellular carcinoma tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B surface antigen produced by a human hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B surface antigen produced by a human hepatoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Vertical Transmission of Hepatitis B Antigen in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Anti-e in primary hepatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Avian leukosis virus-induced tumors have common proviral integration sites and synthesize discrete new RNAs: oncogenesis by promoter insertion

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Sex differences in response to hepatitis B infection among patients receiving chronic dialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Association of hepatitis B virus infection with hepatocellular carcinoma in American patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Serological relationship of woodchuck hepatitis virus to human hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2881%2980329-2

7 January 2021

Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea

series ordinal

13

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

Distribution of five antigens in hepatocellular carcinoma

14 September 2023

series ordinal

16

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

Marmota monax: a model for studies of cardiovascular, cerebrovascular and neoplastic disease

14 September 2023

series ordinal

34

1 reference

https://api.crossref.org/works/10.1016/S0046-8177(81)80329-2

14 September 2023

Identifiers

1 reference

22 May 2018

PubMed ID

6277763

1 reference

22 May 2018